載入中
NASDAQHealthcareDrug Manufacturers - Specialty & Generic
最新資料
US$3.63
−US$0.39 · -9.70%
Based in Princeton, Canada, Optimi Health Corp., established in 2020, is a Canadian entity focused on manufacturing pharmaceutical and nutraceutical products. The company produces and supplies controlled substances, including finalized MDMA and psilocybin drug products, directly to authorized clinics, pharmacies, research trials, and collaborative partners. Their diverse product portfolio extends to MDMA, natural psilocybin, psilocin, other psychedelic compounds, and functional mushrooms, all derived from botanical sources and aimed at the health and wellness market. Optimi Health's operations span cultivation, processing, and distribution of raw mushroom biomass, alongside the creation of mushroom extracts, pharmaceutical drug products, and dietary supplements. These items are available for purchase through the Amazon marketplace, via distributors and brokers, and directly online.
前收盤價
US$3.63
−US$0.39 · -9.70%
盤中時間採用ET。市場資料可能有所延遲。
Based in Princeton, Canada, Optimi Health Corp., established in 2020, is a Canadian entity focused on manufacturing pharmaceutical and nutraceutical products. The company produces and supplies controlled substances, including finalized MDMA and psilocybin drug products, directly to authorized clinics, pharmacies, research trials, and collaborative partners. Their diverse product portfolio extends to MDMA, natural psilocybin, psilocin, other psychedelic compounds, and functional mushrooms, all derived from botanical sources and aimed at the health and wellness market. Optimi Health's operations span cultivation, processing, and distribution of raw mushroom biomass, alongside the creation of mushroom extracts, pharmaceutical drug products, and dietary supplements. These items are available for purchase through the Amazon marketplace, via distributors and brokers, and directly online.
日內區間
目前US$3.63
52週區間
目前US$3.63
盤中時間採用ET。市場資料可能有所延遲。
Based in Princeton, Canada, Optimi Health Corp., established in 2020, is a Canadian entity focused on manufacturing pharmaceutical and nutraceutical products. The company produces and supplies controlled substances, including finalized MDMA and psilocybin drug products, directly to authorized clinics, pharmacies, research trials, and collaborative partners. Their diverse product portfolio extends to MDMA, natural psilocybin, psilocin, other psychedelic compounds, and functional mushrooms, all derived from botanical sources and aimed at the health and wellness market. Optimi Health's operations span cultivation, processing, and distribution of raw mushroom biomass, alongside the creation of mushroom extracts, pharmaceutical drug products, and dietary supplements. These items are available for purchase through the Amazon marketplace, via distributors and brokers, and directly online.
日內區間
目前US$3.63
52週區間
目前US$3.63
獲利能力占已公布營收的百分比。
營收
營業利益
淨利
| 項目（CAD） | 2025會計年度 | 2024會計年度 | 2023會計年度 | 2022會計年度 | 2021會計年度 |
|---|---|---|---|---|---|
| 營收 | 42.69萬 CAD | 38.99萬 CAD | 18.11萬 CAD | 8.07萬 CAD | — |
| 銷貨成本 | 250.35萬 CAD | 11.89萬 CAD | 33.81萬 CAD | 2.68萬 CAD | — |
| 毛利 | −207.66萬 CAD | 27.09萬 CAD | −15.7萬 CAD | 5.39萬 CAD | — |
| 研究與開發 | 34.82萬 CAD | 14.45萬 CAD | 15.21萬 CAD | 13.32萬 CAD | 24.09萬 CAD |
| 銷售、一般及管理費用 | 272.13萬 CAD | 399.21萬 CAD | 393.35萬 CAD | 613.99萬 CAD | 506.21萬 CAD |
| 營業費用 | 245.84萬 CAD | 588.01萬 CAD | 422.36萬 CAD | 744.37萬 CAD | 605.54萬 CAD |
| 利息收入 | 1.43萬 CAD | 2665 CAD | 13.64萬 CAD | 6.69萬 CAD | 5.5萬 CAD |
| 利息支出 | 53.24萬 CAD | 42.93萬 CAD | 4.37萬 CAD | 2.8萬 CAD | 1.92萬 CAD |
| 折舊和攤銷 | 95.03萬 CAD | 86.79萬 CAD | 72.96萬 CAD | 29.36萬 CAD | 4.71萬 CAD |
| 營業利益 | −453.5萬 CAD | −560.92萬 CAD | −438.06萬 CAD | −738.98萬 CAD | −605.54萬 CAD |
| 淨利 | −371.73萬 CAD | −603.59萬 CAD | −519.45萬 CAD | −735.08萬 CAD | −601.95萬 CAD |
公司資料更新於 2026年10月13日。
近期已公布業績
近期已公布業績
報告持有此股票曝險的交易所交易基金。
AI 生成內容及延遲市場資料僅供資訊與教育用途，不構成投資建議。
